Clinical trial
A Multicenter, Randomized, Double-blind Clinical Trial to Evaluate the Efficacy and Safety of BT-KTM-I Versus Ketanest® S for General Anesthesia in Elective Laparoscopic Surgery
NCT06092684 is registered in ClinicalTrials.gov with Chengdu Brilliant Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind Clinical Trial to Evaluate the Efficacy and Safety of BT-KTM-I Versus Ketanest® S for General Anesthesia in Elective Laparoscopic Surgery
- Lead sponsor
- Chengdu Brilliant Pharmaceutical Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 20, 2023
- Completion date
- March 19, 2024
- Enrollment
- 358 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
anesthesia, intravenous, laparoscopy